{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:55:21Z","timestamp":1787028921106,"version":"build-2736575974"},"reference-count":33,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background: Patient-reported outcomes are integral to chronic coronary syndrome (CCS) care. The Seattle Angina Questionnaire (SAQ) is validated and prognostic, yet its clinical integration in Bulgaria is undefined. Aim: The aim of this study was to provide a structured, clinically oriented framework for integrating the SAQ into the full CCS care pathway\u2014from screening and phenotyping (obstructive vs. ANOCA\/INOCA endotypes) to diagnostics, mechanism-tailored therapy, and follow-up\u2014while outlining a pragmatic roadmap for Bulgarian implementation. Methods: We conducted a semi-structured narrative review (1995\u20132024) of SAQ\u2019s validation, prognostic utility, and implementation in the literature, augmented with guideline-based frameworks for CCS\/ANOCA care. Results: The SAQ (and SAQ-7) shows strong reliability and responsiveness and independently predicts health status and clinical outcomes. Embedding the SAQ at baseline, at 4\u201312 weeks after therapy changes, and after 6\u201312 months enables symptom-guided decision-making. A phenotype-guided pathway is proposed that couples the SAQ with CAD burden assessment and\u2014where indicated\u2014ANOCA diagnostics (CFR\/IMR, vasoreactivity testing). Mechanism-tailored therapy maps to endotypes (e.g., VSA \u2192 CCB \u00b1 nitrates; MVA \u2192 beta-blocker\/ACEi\/statin \u00b1 ranolazine; obstructive CADGDMT \u00b1 PCI\/CABG). A minimum dataset, metrics, and registry fields are specified for Bulgarian deployment. Conclusions: A clinically structured framework clarifies how the SAQ adds value beyond description\u2014by informing triage, treatment selection, and follow-up across CCS phenotypes. This approach provides educational guidance and a practical blueprint for pilot implementation in Bulgaria.<\/jats:p>","DOI":"10.3390\/medicina61111924","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T11:47:19Z","timestamp":1761652039000},"page":"1924","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Seattle Angina Questionnaire and Quality of Life in Chronic Coronary Syndrome: Opportunities for Implementation in Bulgarian Clinical Practice\u2014A Narrative Review"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0174-5084","authenticated-orcid":false,"given":"Velina","family":"Doktorova","sequence":"first","affiliation":[{"name":"First Department of Internal Diseases, Section of Cardiology, Medical University of Plovdiv, 4000 Plovdiv, Bulgaria"},{"name":"Department of Interventional Cardiology, University Multiprofile Hospital for Active Treatmen \u201cSveti Georgi\u201d, 4000 Plovdiv, Bulgaria"},{"name":"Department of Cardiovascular Surgery, Medical University of Plovdiv, 4000 Plovdiv, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgi","family":"Goranov","sequence":"additional","affiliation":[{"name":"First Department of Internal Diseases, Section of Cardiology, Medical University of Plovdiv, 4000 Plovdiv, Bulgaria"},{"name":"Department of Interventional Cardiology, University Multiprofile Hospital for Active Treatmen \u201cSveti Georgi\u201d, 4000 Plovdiv, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petar","family":"Nikolov","sequence":"additional","affiliation":[{"name":"First Department of Internal Diseases, Section of Cardiology, Medical University of Plovdiv, 4000 Plovdiv, Bulgaria"},{"name":"Department of Interventional Cardiology, University Multiprofile Hospital for Active Treatmen \u201cSveti Georgi\u201d, 4000 Plovdiv, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/eurheartj\/ehab892","article-title":"European Society of Cardiology: Cardiovascular Disease Statistics 2021","volume":"43","author":"Timmis","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC Guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_4","first-page":"1434","article-title":"2023 ACC\/AHA Guideline for the Management of Patients With Chronic Coronary Disease","volume":"81","author":"Virani","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_5","unstructured":"National Statistical Institute of Bulgaria (2022). Health Statistics Report, National Statistical Institute of Bulgaria."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Barbazza, E., Kringos, D., Kruse, I., Klazinga, N., and Tello, J.E. (2019). Creating performance intelligence for primary health care strengthening in Europe. BMC Health Serv. Res., 19.","DOI":"10.1186\/s12913-019-4853-z"},{"key":"ref_7","first-page":"i21","article-title":"Cardiovascular risk factors and ischemic heart disease prevalence in Bulgaria: National survey results","volume":"28","author":"Dimitrov","year":"2021","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_8","first-page":"161","article-title":"Future of health systems to 2030: A roadmap for global progress and sustainability","volume":"400","author":"Dzau","year":"2022","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0735-1097(94)00397-9","article-title":"Development and evaluation of the Seattle Angina Questionnaire: A new functional status measure for coronary artery disease","volume":"25","author":"Spertus","year":"1995","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJMoa072771","article-title":"Effect of PCI vs. medical therapy on quality of life in patients with stable coronary disease: The COURAGE Trial","volume":"359","author":"Weintraub","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/01.CIR.0000020688.24874.90","article-title":"Health status predicts long-term outcome in outpatients with coronary disease","volume":"106","author":"Spertus","year":"2002","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease (ISCHEMIA)","volume":"382","author":"Maron","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/eurheartj\/ehy220","article-title":"EuroCTO randomized trial: Revascularization vs. optimal medical therapy for CTO","volume":"39","author":"Werner","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_14","first-page":"56","article-title":"Interpreting the Seattle Angina Questionnaire as an outcome measure in clinical trials and clinical care: A state-of-the-art review","volume":"236","author":"Arnold","year":"2021","journal-title":"Am. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12955-020-01627-2","article-title":"Psychometric evaluation of a Canadian version of the Seattle Angina Questionnaire","volume":"18","author":"Lawal","year":"2020","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1161\/CIRCOUTCOMES.114.000967","article-title":"Development and validation of a short version of the Seattle Angina Questionnaire (SAQ-7)","volume":"7","author":"Chan","year":"2014","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.ahj.2009.03.021","article-title":"Impact of dyspnea on HRQoL in stable angina: Results from the PREMIER registry","volume":"157","author":"Arnold","year":"2009","journal-title":"Am. Heart J."},{"key":"ref_18","first-page":"57","article-title":"The TRIUMPH registry: Evaluating health status outcomes in acute myocardial infarction","volume":"163","author":"Spertus","year":"2012","journal-title":"Am. Heart J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.hlc.2012.12.013","article-title":"The Design and Rationale of the Australian Cooperative National Registry of Acute Coronary care, Guideline Adherence and Clinical Events (CONCORDANCE)","volume":"22","author":"Ranasinghe","year":"2013","journal-title":"Heart Lung Circ."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med. Care"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual. Life Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-7525-2-3","article-title":"The MacNew Heart Disease health-related quality of life instrument: A summary","volume":"2","author":"Lim","year":"2004","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1200\/JCO.2004.06.078","article-title":"Measuring quality of life in routine oncology practice improves communication and patient well-being: A randomized controlled trial","volume":"22","author":"Velikova","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s41687-018-0061-6","article-title":"How do patient-reported outcome measures (PROMs) support clinician\u2013patient communication and patient care? A realist synthesis","volume":"2","author":"Greenhalgh","year":"2018","journal-title":"J. Patient Rep. Outcomes"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1016\/j.jacc.2018.09.042","article-title":"Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review","volume":"72","author":"Taqueti","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_26","first-page":"1797","article-title":"Validation of the Seattle Angina Questionnaire in women with ischemic heart disease","volume":"122","author":"Patel","year":"2018","journal-title":"Am. J. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hsdr05020","article-title":"Functionality and feedback: A realist synthesis of patient-reported outcome measure use in clinical practice","volume":"5","author":"Greenhalgh","year":"2017","journal-title":"Health Serv. Deliv. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1524-4733.2005.04054.x","article-title":"Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures","volume":"8","author":"Wild","year":"2005","journal-title":"Value Health"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1524-4733.2007.00292.x","article-title":"Literature review of methods to translate health-related quality of life questionnaires for use in multinational clinical trials","volume":"11","author":"Acquadro","year":"2008","journal-title":"Value Health"},{"key":"ref_30","first-page":"1145","article-title":"Health-related quality of life in Polish patients with coronary artery disease: Validation of tools and cross-cultural adaptation challenges","volume":"68","author":"Jankowska","year":"2010","journal-title":"Kardiol. Pol."},{"key":"ref_31","first-page":"77","article-title":"Translation and psychometric testing of the Farsi version of the Seattle Angina Questionnaire","volume":"16","author":"Rejeh","year":"2017","journal-title":"Payesh"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1161\/CIR.0b013e3182949a2e","article-title":"Cardiovascular health: The importance of measuring patient-reported health status: A scientific statement from the American Heart Association","volume":"127","author":"Rumsfeld","year":"2013","journal-title":"Circulation"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","article-title":"Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial","volume":"34","author":"Basch","year":"2016","journal-title":"J. Clin. Oncol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/11\/1924\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T12:46:10Z","timestamp":1761655570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/11\/1924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":33,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["medicina61111924"],"URL":"https:\/\/doi.org\/10.3390\/medicina61111924","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]}}}